+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Newborn Screening Market Size, Share & Industry Trends Analysis Report By Product Type (Consumables and Instrument), By Test Type (Blood Test, Hearing Screening Test, and Heart screening), By End User, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 106 Pages
  • June 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5636303
The Europe Newborn Screening Market is expected to witness market growth of 6.2% CAGR during the forecast period (2022-2028).

Before the newborn leaves the hospital, usually within the first two days of his or her life, a blood sample is taken from the baby's ankle. It is recommended that a blood sample be taken after the first 24 hours of life. It is possible to examine newborns within 24 hours because mothers and newborns can sometimes be discharged within one day. If this happens, doctors advise waiting one to two weeks before collecting another sample.

Several health problems discovered by neonatal screening are hereditary. Inherited refers to something that is passed on from one generation down the generations from one parent to the next. Genes are instructions for how the human body grows and works that are stored in the cells of the body. Whenever one kid in a household has a hereditary health issue, the chances of a brother or sister developing the same illness are higher than if no one in the family has it. A genetic counselor is someone who has been trained to explain genes, birth abnormalities, and other medical disorders that run-in families, as well as how they can affect parents' health and the health of the kid. Hearing loss may not always be hereditary. Infection during pregnancy can cause it. In this scenario, it is unusual for it to occur again in a subsequent pregnancy.

Pregnant women with health insurance in Germany are often offered three routine ultrasound scans at no additional cost. Occasionally, they are referred to as screening tests. These three standard ultrasound scans are used to determine if the pregnancy and the child's growth are progressing correctly. In general, 96 to 98 percent of pregnant women give delivery to a healthy baby. However, anomalies detected by ultrasound may necessitate further investigations and, in certain cases, difficult judgments.

The Germany market dominated the Europe Newborn Screening Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $100.2 Million by 2028. The UK market is experiencing a CAGR of 5.3% during (2022-2028). Additionally, The France market is exhibiting a CAGR of 7% during (2022-2028).

Based on Product Type, the market is segmented into Consumables and Instrument. Based on Test Type, the market is segmented into Blood Test, Hearing Screening Test, and Heart screening. Based on End User, the market is segmented into Hospitals and Clinical Laboratories. Based on Technology, the market is segmented into Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays & Enzymatic Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Natus Medical Incorporated, Masimo Corporation, Waters Corporation, PerkinElmer, Inc., AB Sciex LLC (Danaher Corporation), Medtronic PLC (Covidien plc), Trivitron Healthcare Pvt. Ltd.

Scope of the Study


Market Segments Covered in the Report:


By Product Type
  • Consumables
  • Instrument
By Test Type
  • Blood Test
  • Hearing Screening Test
  • Heart screening
By End User
  • Hospitals
  • Clinical Laboratories
By Technology
  • Tandem Mass Spectrometry (TMS)
  • Molecular Assays
  • Immunoassays & Enzymatic Assays
  • Hearing Screen Technology
  • Pulse Oximetry Screening Technology
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players


List of Companies Profiled in the Report:

  • General Electric (GE) Co. (GE Healthcare)
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Natus Medical Incorporated
  • Masimo Corporation
  • Waters Corporation
  • PerkinElmer, Inc.
  • AB Sciex LLC (Danaher Corporation)
  • Medtronic PLC (Covidien plc)
  • Trivitron Healthcare Pvt. Ltd.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Newborn Screening Market, by Product Type
1.4.2 Europe Newborn Screening Market, by Test Type
1.4.3 Europe Newborn Screening Market, by End User
1.4.4 Europe Newborn Screening Market, by Technology
1.4.5 Europe Newborn Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Newborn Screening Market
Chapter 4. Europe Newborn Screening Market by Product Type
4.1 Europe Consumables Market by Country
4.2 Europe Instrument Market by Country
Chapter 5. Europe Newborn Screening Market by Test Type
5.1 Europe Blood Test Market by Country
5.2 Europe Hearing Screening Test Market by Country
5.3 Europe Heart screening Market by Country
Chapter 6. Europe Newborn Screening Market by End User
6.1 Europe Hospitals Market by Country
6.2 Europe Clinical Laboratories Market by Country
Chapter 7. Europe Newborn Screening Market by Technology
7.1 Europe Tandem Mass Spectrometry (TMS) Market by Country
7.2 Europe Molecular Assays Market by Country
7.3 Europe Immunoassays & Enzymatic Assays Market by Country
7.4 Europe Hearing Screen Technology Market by Country
7.5 Europe Pulse Oximetry Screening Technology Market by Country
7.6 Europe Others Market by Country
Chapter 8. Europe Newborn Screening Market by Country
8.1 Germany Newborn Screening Market
8.1.1 Germany Newborn Screening Market by Product Type
8.1.2 Germany Newborn Screening Market by Test Type
8.1.3 Germany Newborn Screening Market by End User
8.1.4 Germany Newborn Screening Market by Technology
8.2 UK Newborn Screening Market
8.2.1 UK Newborn Screening Market by Product Type
8.2.2 UK Newborn Screening Market by Test Type
8.2.3 UK Newborn Screening Market by End User
8.2.4 UK Newborn Screening Market by Technology
8.3 France Newborn Screening Market
8.3.1 France Newborn Screening Market by Product Type
8.3.2 France Newborn Screening Market by Test Type
8.3.3 France Newborn Screening Market by End User
8.3.4 France Newborn Screening Market by Technology
8.4 Russia Newborn Screening Market
8.4.1 Russia Newborn Screening Market by Product Type
8.4.2 Russia Newborn Screening Market by Test Type
8.4.3 Russia Newborn Screening Market by End User
8.4.4 Russia Newborn Screening Market by Technology
8.5 Spain Newborn Screening Market
8.5.1 Spain Newborn Screening Market by Product Type
8.5.2 Spain Newborn Screening Market by Test Type
8.5.3 Spain Newborn Screening Market by End User
8.5.4 Spain Newborn Screening Market by Technology
8.6 Italy Newborn Screening Market
8.6.1 Italy Newborn Screening Market by Product Type
8.6.2 Italy Newborn Screening Market by Test Type
8.6.3 Italy Newborn Screening Market by End User
8.6.4 Italy Newborn Screening Market by Technology
8.7 Rest of Europe Newborn Screening Market
8.7.1 Rest of Europe Newborn Screening Market by Product Type
8.7.2 Rest of Europe Newborn Screening Market by Test Type
8.7.3 Rest of Europe Newborn Screening Market by End User
8.7.4 Rest of Europe Newborn Screening Market by Technology
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.1 Financial Analysis
9.1.2 Segmental and Regional Analysis
9.1.3 Research & Development Expense
9.1.4 Recent strategies and developments
9.1.4.1 Acquisition and Mergers
9.1.5 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Bio-Rad laboratories, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Natus Medical Incorporated
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments
9.4.5.1 Partnerships, Collaborations, and Agreements
9.4.5.2 Acquisition and Mergers
9.5 Masimo Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments
9.5.5.1 Product Launches and Product Expansions
9.5.5.2 Approvals and Trials
9.6 Waters Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 PerkinElmer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments
9.7.5.1 Approvals and Trials
9.8 AB Sciex LLC (Danaher Corporation)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Medtronic PLC (Covidien plc)
9.9.1 Company overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 SWOT Analysis
9.10. Trivitron Healthcare Pvt. Ltd.
9.10.1 Company Overview

Companies Mentioned

  • General Electric (GE) Co. (GE Healthcare)
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Natus Medical Incorporated
  • Masimo Corporation
  • Waters Corporation
  • PerkinElmer, Inc.
  • AB Sciex LLC (Danaher Corporation)
  • Medtronic PLC (Covidien plc)
  • Trivitron Healthcare Pvt. Ltd.

Methodology

Loading
LOADING...